Filing Flows › Roivant Sciences (ROIV) › Who owns the stock
Who owns Roivant Sciences (ROIV) stock
0 funds reported Roivant Sciences (ROIV) shares in their latest 13F filings. Members of Congress and other officials disclosed 1 trade (0 buys, 1 sales).
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2025-10-31 | Lisa McClain | sale | $1K–$15K |
Roivant Sciences' latest quarter
Roivant Sciences, Q1 FY27: revenue $1.4M (-34% year over year), net loss $291M, operating cash flow −$271M. The chart follows the revenue to costs, profit and cash.
Questions
Has Congress traded ROIV stock?
Officials disclosed 1 trade on file: 0 buys and 1 sales. The latest: Lisa McClain, sale on 2025-10-31.
What is the short interest in ROIV?
40,302,998 shares were sold short at the 2026-10-15 settlement, 2.56% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.